Last updated on January 2020

Effectiveness Study of Nivolumab Compared to Placebo in Prevention of Recurrent Melanoma After Complete Resection of Stage IIB/C Melanoma


Brief description of study

The purpose of this study is to determine the effectiveness of nivolumab adjuvant immunotherapy compared to placebo in adults and pediatric participants after complete resection of Stage IIB/C melanoma with no evidence of disease (NED) who are at high risk for recurrence.

Clinical Study Identifier: NCT04099251

Find a site near you

Start Over

Greenslopes Private Hospital

Melbourne, Australia
6.21miles
  Connect »

Local Institution

Melbourne, Australia
6.21miles
  Connect »

Local Institution

Malvern, Australia
8.02miles
  Connect »

Local Institution

Box Hill, Australia
8.18miles
  Connect »